SB 931 (see companion bill HB 652) – Maryland

Status: Enacted
Year Introduced: 2020
Year Enacted: 2020

Maryland Medical Assistance Program and Health Insurance – Specialty Drugs – Definition. Prohibiting the Secretary of Health from considering certain drugs to be specialty drugs for the purposes of providing services under the Maryland Medical Assistance Program; altering the definition of “specialty drug” for the purpose of excluding prescription drugs prescribed to treat certain conditions from the authority of certain insurers, nonprofit health service plans, and health maintenance organizations to require certain drugs be obtained through a certain pharmacy and to provide coverage through a managed care system; etc.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found